Cancer vaccines and the next frontier in melanoma: From headlines to scientific evidence By Ogkologos - October 14, 2026 6 0 Facebook Twitter Google+ Pinterest WhatsApp Source RELATED ARTICLESMORE FROM AUTHOR Five-Year Survival Outcomes with Neoadjuvant Therapy in Melanoma Demonstrate that Neoadjuvant ICIs Exceeded Adjuvant Benchmarks Giredestrant plus everolimus prolongs PFS among patients with ER-positive, HER2-negative, ESR1-mutated advanced breast cancer after the receipt of a CDK4/6 inhibitor EMA Recommends Granting a Marketing Authorisation for Ensartinib MOST POPULAR Using Immunotherapy to Treat Advanced Melanoma and Advanced Non-Small Cell Lung... March 14, 2022 Brentuximab May Mean Less Radiation for Children, Teens with Hodgkin Lymphoma May 7, 2021 What Do You Put In Your Pocket? April 28, 2021 EMA Recommends Granting a Marketing Authorisation for the Medicinal Product Nyvepria October 2, 2020 Load more HOT NEWS Intratumoural and Intracavitary Administration of Ipilimumab Plus Nivolumab Is Feasible and... Data from a Large Cohort of Patients with mRCC Demonstrate the... Cancer Research UK appoints new Trustees and independent Committee Members FDA Grants Regular Approval to fam-Trastuzumab Deruxtecan-nxki for Unresectable or Metastatic...
